RTx_Dual_Induction_-_Supplementary_Material_-_20200807 – Supplemental material for Incidence, Risk Factors, and Outcomes of Kidney Transplant Recipients Treated With Both Basiliximab and Antithymocyte Globulin

Rachel Jeong, Robert R. Quinn, Krista L. Lentine, Pietro Ravani, Feng Ye, Patricia Campbell, Kevin Wen, Chris Broscheit, Sita Gourishankar & Ngan N. Lam
Supplemental material, RTx_Dual_Induction_-_Supplementary_Material_-_20200807 for Incidence, Risk Factors, and Outcomes of Kidney Transplant Recipients Treated With Both Basiliximab and Antithymocyte Globulin by Rachel Jeong, Robert R. Quinn, Krista L. Lentine, Pietro Ravani, Feng Ye, Patricia Campbell, Kevin Wen, Chris Broscheit, Sita Gourishankar and Ngan N. Lam in Canadian Journal of Kidney Health and Disease
This data repository is not currently reporting usage information. For information on how your repository can submit usage information, please see our documentation.